Anika Therapeutics press release (ANIK): Q3 GAAP EPS of -$0.02 misses by $0.08. – Revenue of $30.59M (+10.0% Y/Y) beats by $1.15M. – Total third quarter revenue was $30.6 million, up 10% year over year, reflecting continued execution across Commercial and OEM Channels. -…
mmercial Channel revenue increased 17% year over year to $14.0 million, supported by international viscosupplement growth and Integrity adoption